Taken together, these results indicate that Ipra reduces UAE as well as hyperglycemia in HFD-fed mice, and that Ipra increases lipogenesis and lipolysis capacity while enhancing insulin signaling in PRAT of HFD-fed mice. This evidence concerns the gene INS and Hyperglycemia.